Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by ProShare Advisors LLC

ProShare Advisors LLC lessened its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 44.0% during the fourth quarter, HoldingsChannel reports. The firm owned 191,482 shares of the pharmacy operator’s stock after selling 150,594 shares during the period. ProShare Advisors LLC’s holdings in Walgreens Boots Alliance were worth $1,787,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of WBA. Golden State Wealth Management LLC purchased a new position in shares of Walgreens Boots Alliance during the 4th quarter valued at approximately $26,000. Riverview Trust Co grew its holdings in Walgreens Boots Alliance by 123.8% during the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock worth $27,000 after acquiring an additional 1,590 shares in the last quarter. Colonial Trust Co SC grew its stake in Walgreens Boots Alliance by 79.5% in the fourth quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator’s stock worth $27,000 after purchasing an additional 1,297 shares in the last quarter. Venturi Wealth Management LLC bought a new stake in shares of Walgreens Boots Alliance in the 4th quarter valued at approximately $28,000. Finally, Independence Bank of Kentucky acquired a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth $39,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. Truist Financial reduced their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a report on Friday, January 31st. StockNews.com assumed coverage on shares of Walgreens Boots Alliance in a research report on Wednesday. They issued a “hold” rating for the company. Deutsche Bank Aktiengesellschaft downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating and dropped their price objective for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Finally, Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $10.59.

Get Our Latest Analysis on Walgreens Boots Alliance

Walgreens Boots Alliance Stock Down 0.4%

Walgreens Boots Alliance stock opened at $11.18 on Thursday. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $16.74. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The firm has a market cap of $9.67 billion, a PE ratio of -1.09, a P/E/G ratio of 1.31 and a beta of 0.77. The firm’s 50 day moving average price is $11.02 and its two-hundred day moving average price is $10.39.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last posted its quarterly earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, beating the consensus estimate of $0.53 by $0.10. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business had revenue of $38.59 billion for the quarter, compared to analysts’ expectations of $37.90 billion. During the same period in the previous year, the company posted $1.20 EPS. Walgreens Boots Alliance’s revenue was up 4.1% on a year-over-year basis. On average, research analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Insider Activity at Walgreens Boots Alliance

In other news, Chairman Stefano Pessina acquired 832,258 shares of the company’s stock in a transaction that occurred on Sunday, April 27th. The shares were purchased at an average price of $11.01 per share, for a total transaction of $9,163,160.58. Following the completion of the acquisition, the chairman now owns 145,621,079 shares of the company’s stock, valued at approximately $1,603,288,079.79. This represents a 0.57% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 17.50% of the company’s stock.

Walgreens Boots Alliance Company Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Articles

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.